产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Pantoprazole So...

Pantoprazole Sodium for Injection

2025-02-07
成都市

产品详情

Pantoprazole Sodium for Injection
消化系统制剂
Pantoprazole Sodium for Injection
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

Active ingredients: pantoprazole sodium.
Description: a white to off-white porous cake or powder.

Dosage Form: lyophilized powder for injection.
Indications: duodenal ulcer; Gastric ulcer, moderate to severe gastroesophageal reflux disease, acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, combined gastric ulcer.

Strength: 40mg/vial,80mg/vial

Storage: Keep airtight in a cool place. Away from light.

Packaging: low borosillicate tubular vial with a bromobutyl rubber stopper .10 vials/box  (Can be customized based on customer's order.)

Shelf Life: 24 months.
Dosage and Administration:
Acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, combined gastric: Duodenal ulcer; Gastric ulcer, moderate to severe gastroesophageal reflux disease: 40 mg every 24 hours, Reconstitute each vial of Pantoprazole Sodium for Injection with 10 ml of 0.9% Sodium Chloride Injection, Administer intravenously over a period of more than 2 minutes, or reconstitute with 100ml~250ml of 0.9% Sodium Chloride Injection and administer intravenously over a period of not less than 15 minutes.
Dissolution and dilution must be performed within 4 hours, do not use other solvents or drugs for dissolution and dilution.

 

 

CDMO Service Undertaking

Dosage Form

Production Lines

Annual Capacity 

Injection

8

650,000,000

Oral Solid

3

700,000,000

API & Intermediates

3

8,000 Kg

TCM Extraction

2

5,000,000 Kg 

Baiyu provide CDMO service for:

FDFs & APIs
Primary & secondary packaging
Warehousing
Commercial scale, pilot scale, laboratory scale

You are warmly welcomed to contact us for business cooperation.

sales@baiyu.cn

Chengdu Baiyu Pharmaceutical Co., Ltd.

www.baiyujituan.com

 

四川宏明博思药业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

四川宏明博思药业有限公司成立于2013年,专注于原料药和制剂的生产。现有员工400余人,主要生产高端剂型如注射剂、冻干粉针剂、片剂和胶囊剂。宏明博思的冻干粉针制剂生产线已获得EU GMP,并通过巴西ANVISA现场检查。目前四川宏明博思冻干粉针制剂的多个产品在巴西、智利、秘鲁、危地马拉、泰国、菲律宾、马来西亚、南非、澳大利亚等开展注册中。Sichuan Omnis Pharmaceutical Co., Ltd. was established in 2013, focusing on the manufacture of FDFs and APIs, located in Sichuan Chengdu, China. It currently has more than 400 employees and mainly produces high-end dosage forms such as injections, lyophilized powder injections, tablets and capsules. Omnis has granted China/EU/ANVISA/PICs GMP for lyophilized powder injection line. Currently, multiple products of lyophilized powder injection are undergoing registration in Brazil, Chile, Peru, Guatemala, Thailand, the Philippines, Malaysia, South Africa, Australia, and other countries.
业务类型:
成立日期:
年营业额:
主营产品类别: